Company Profile: Getlabs
Background
Getlabs, founded in 2018, is a healthcare technology company headquartered in Santa Monica, California. The company specializes in providing at-home diagnostic services by dispatching certified mobile phlebotomists to collect lab samples from patients' homes, which are then delivered to partner laboratories for testing. This service aims to enhance patient adherence to diagnostic testing and improve overall healthcare accessibility.
Key Strategic Focus
Getlabs focuses on expanding access to diagnostics by offering convenient, at-home lab collection services. Their core objectives include improving patient adherence to diagnostic testing, reducing the need for in-clinic visits, and enhancing the overall patient experience. The company specializes in mobile phlebotomy services, utilizing a network of certified phlebotomists to collect blood, saliva, stool, urine, and breath samples. Key technologies employed include a proprietary scheduling platform for at-home diagnostics and integrations with major diagnostic laboratories like Labcorp and Quest Diagnostics. Primary markets targeted are healthcare organizations, including health systems, health plans, payors, providers, employers, clinical research organizations, EHRs, and telehealth companies.
Financials and Funding
As of April 2026, Getlabs has raised a total of $41.69 million across three funding rounds. The most recent funding round was a Series B round of $18.69 million completed in August 2023. Notable investors include LabCorp, Emerson Collective, and Minderoo Foundation. The capital raised is intended to support the company's expansion efforts, enhance its technological platform, and broaden its service offerings to improve patient care and operational efficiency.
Pipeline Development
Getlabs offers a comprehensive suite of diagnostic services, including blood draws, vitals checks, urine collection, and mobile imaging. The company has established partnerships with major diagnostic laboratories such as Labcorp and Quest Diagnostics to process and analyze collected samples. While specific timelines for new service rollouts are not publicly disclosed, Getlabs continues to expand its service offerings and geographic reach to meet the growing demand for at-home diagnostics.
Technological Platform and Innovation
Getlabs utilizes a proprietary technology platform that facilitates the scheduling and management of at-home diagnostic appointments. This platform integrates with partner laboratories to streamline the collection, processing, and reporting of diagnostic results. The company's mobile phlebotomy network is supported by advanced routing and dispatching technologies to ensure timely and efficient service delivery. Additionally, Getlabs emphasizes data security and compliance, adhering to SOC 2 Type II and HIPAA standards to protect patient information.
Leadership Team
- Claire Hough: Chief Executive Officer. Claire brings extensive experience in scaling mission-driven companies, having previously served as Chief Product and Technology Officer at Getlabs.
- Kyle Michelson: Founder and CEO. Prior to founding Getlabs, Kyle was the CEO of Streamup and participated in Y Combinator.
- Scott Albrecht: Vice President of Operations & Finance. Scott has a background in operations and finance, previously working at SWORD Health.
- David Shin: Vice President of Partnerships. David has experience in partnership development, having worked at Ephemeral.
- Isaac Appiah: Head of Design & Creative. Isaac has a background in design and creative direction, previously working at Saatchi & Saatchi.
- Amanda Souders: Vice President of People. Amanda has experience in human resources and organizational development, having worked at Fair.
Leadership Changes
In June 2025, Claire Hough was appointed as the new CEO of Getlabs, succeeding Kyle Michelson, who remains with the company as Founder and CEO.
Market Insights and Dynamics
The at-home diagnostics market is experiencing significant growth, driven by increasing patient demand for convenient healthcare services and advancements in telehealth technologies. The market size is expanding as healthcare organizations seek to improve patient adherence and close gaps in care through remote diagnostics.
Competitor Analysis
Key competitors in the at-home diagnostics space include:
- Sprinter Health: Provides in-home phlebotomy services facilitated via an online booking platform.
- TravaLab: Operates an online platform for scheduling phlebotomy appointments.
- Bioreach: Offers blood testing services for individuals.
- Lab@Home: Provides at-home lab testing services booked via an online platform.
- Accesa Labs: A digital hub enabling users to order and manage home-based blood test kits conveniently.
These competitors vary in their service offerings, technological platforms, and market reach, contributing to a dynamic and competitive landscape in the at-home diagnostics industry.
Strategic Collaborations and Partnerships
Getlabs has established strategic partnerships with major diagnostic laboratories, including Labcorp and Quest Diagnostics, to process and analyze collected samples. These collaborations enhance the company's service offerings and expand its reach in the healthcare market.
Operational Insights
In comparison to major competitors like Labcorp and Quest Diagnostics, Getlabs differentiates itself by offering a specialized at-home diagnostic collection service, focusing on patient convenience and adherence. The company's nationwide mobile phlebotomy network and integration with leading diagnostic laboratories position it as a significant player in the at-home diagnostics market.
Strategic Opportunities and Future Directions
Getlabs is well-positioned to capitalize on the growing demand for at-home healthcare services by expanding its service offerings and geographic reach. The company's focus on patient-centric solutions and strategic partnerships with diagnostic laboratories provide a solid foundation for future growth and innovation in the healthcare sector.
